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Summary The staining pattern of a monoclonal antibody directed to the monomorphic determinant of
HLA-DR antigens was examined on sections of human mammary gland tissues at various stages of
differentiation as well as on 50 benign and 72 malignant breast lesions. Normal resting breast epithelium
lacked HLA-DR, whereas late-pregnant and lactating epithelia expressed high levels of HLA-DR antigens,
followed by a decline in the post-weaning regression period. Most benign breast lesions revealed
heterogeneous staining ranging from very few up to 20-25% positive epithelial cells. Greater variability was
observed among carcinomas, where a small group (-7%) of cases showing 40-95% positive tumour cells was
found, in addition to negative tumours and those with the minority of HLA-DR expressing carcinoma cells.
The density of the leukocytic infiltrate was higher in carcinomas than in either normal breast tissue or benign
lesions, the HLA-DR phenotype of the mononuclear infiltrating cells lacking any obvious correlation with the
HLA-DR status of the epithelial component. Immunoblotting analyses of whole-tissue lysates separated by
SDS-PAGE confirmed the immunohistochemical data and demonstrated the reactivity with only one protein
band predicted for HLA-DR a-chain. The combination of immunohistochemistry and autoradiography on
sections of human reduction mammoplasty organoids cultured in collagen gels and labelled with tritiated
thymidine revealed a lack of HLA-DR expression on proliferating breast epithelial cells suggesting factors
other than cell kinetics must be responsible for induction of HLA-DR antigens seen in pregnant and lactating
breast epithelium and some tumours.
The human HLA-DR antigens are membrane bound
glycoproteins composed of 34kDa and 28 kDa molecular
weight polypeptides which are encoded by genes located in
the HLA-D region of the major histocompatibility complex
(Bodmer & Bodmer, 1984; Kaufman et al., 1984). These
antigens are commonly expressed on B-lymphocytes,
activated T-lymphocytes, monocytes, macrophages, dendritic
cells in lymph nodes, Langerhans cells of the skin, and
endothelial cells and are believed to regulate essential cell
interactions in immune responses (Kaufman et al., 1984;
Benacerraf, 1985). Numerous studies, recently reviewed by
Forsum et al. (1985), have demonstrated that, in addition to
cells of the immune system, many human epithelial cells
under both normal and pathological conditions may also
express HLA-DR antigens. The importance of class II
antigen expression in non-immune cells is unclear at present
and some investigators have suggested that these molecules
may be viewed as differentiation antigens possibly involved
in various non-immunologic or immunologic functions
(Klareskog et al., 1980; Radka et al., 1986; Tabibzadeh et
al., 1986; Unanue & Allen, 1986).
Among the reports concerning the expression of HLA-DR
antigens on epithelia-derived neoplasms, breast tumours
represent perhaps the most conflicting group of malignancies
with the observed percentage of positive tumours ranging
from zero (Hurliman & Saraga, 1985) or only a few (Bhan &
Des Marais, 1983) up to 100% (Bernard et al., 1984) with
some intermediate values found by Natali et al. (1983),
Whitwell et al. (1984) and Gottlinger et al. (1985). To
illustrate the extent of discrepancies published by various
authors, Hurliman and Saraga (1985) found none of 61
breast carcinomas positive while Bernard et al. (1984)
reported that all 19 mammary carcinomas examined
expressed HLA-DR antigens, despite the fact that a similar
immunohistochemical technique and the same monoclonal
antibody (OK Ia from Ortho) to HLA-DR were used by
both groups of investigators. Similarly, there is disagreement
over the expression of class II molecules on normal human
mammary gland epithelium. Thus, while Natali et al. (1983)
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and Bhan and Des Marais (1983) described heterogeneously
positive staining of the normal breast epithelium by anti-
HLA-DR antibodies, Newman et al. (1980) and Bernard
et al. (1984) reported a complete lack of HLA-DR antigens
on the epithelium of the normal resting breast. These
inconsistencies illustrate the need for further investigations of
the normal human mammary gland epithelium as well as
breast neoplasms before any conclusion regarding possible
relationship between HLA-DR expression and neoplastic
transformation and/or biological behaviour of breast
tumours can be reached. Furthermore, very little is known
about HLA-DR antigens on human breast epithelium during
the important stages of physiological differentiation. In fact,
we found only one report of the expression of HLA-DR
antigens on the epithelium of the human lactating breast
(Newman et al., 1980) suggesting that pronounced
differentiation-associated changes of class II molecules might
occur in the human mammary gland epithelium.
To address the conflicting issues of HLA-DR antigen
expression in the normal human mammary gland epithelium
and breast tumours, we have examined (1) normal breast
tissues at different stages of physiological differentiation, i.e.
the resting, pregnant, lactating and regressing (after weaning)
mammary gland, and (2) a large panel of benign as well as
malignant breast tumours using an anti-HLA-DR mono-
clonal antibody in both immunohistochemistry on paraffin
sections and Western blotting. Finally, we have employed a
three-dimensional collagen gel culture model (Emerman &
Pitelka, 1977) in an attempt to find out whether there is any
correlation between the HLA-DR expression- and the
proliferation rate of the normal human breast epithelial cells.
Materials and methods
Tissues and tumours
All tissue samples were fixed in methacarn (a mixture of
methanol/chloroform/acetic acid, 6:3: 1) and embedded in
paraffin. In about one third, frozen sections from the same
tumour were examined as well. The numbers of tumours
examined and the histopathological diagnoses are shown in
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Table I. Normal breast tissues, both resting (6 cases) and
those at various stages of differentiation (5 cases) were
obtained from autopsy material taken 10-25h post mortem
from women who died of non-breast diseases or were killed
in road accidents (kindly supplied by the Department of
Forensic Medicine, J.E. Purkyn6 University Medical School,
Brno, and the Ist Department of Pathology, Charles'
University Medical School, Prague). Breast tissues from
reduction mammoplasties (3 cases) to be used for immuno-
histochemistry as well as for the preparation of organoids
(see below) were processed within 1-2h after removal.
Monoclonal antibodies
The murine monoclonal antibody TAL-1B5 to a
monomorphic determinant of the HLA-DR a-chain (weakly
cross-reacting with the fl-chain) originally raised by Adams
et al. (1983) and shown to react with fixed and paraffin-
embedded tissues (Epenetos et al., 1985) was kindly donated
by Sir Walter Bodmer (ICRF, London). The anti-keratin
monoclonal antibody BA17 specific for the human 40kDa
cytokeratin was developed and characterized by B'artek et al.
(1985a). The latter antibody proved to be a reliable reagent
for detection of breast carcinoma cells in frozen as well as
methacarn-fixed paraffin-embedded tissue sections (Bairtek et
al., 1985b) and was used in the present study as a positive
control. The TF-l antibody to pig transferrin (Batrtek et al.,
1982) served as a negative control. In both immuno-
histochemistry and staining of Western blots, undiluted
hybridoma tissue culture supernatants were used.
Immunoperoxidase staining
The indirect immunoperoxidase technique used in this study
was performed as previously described (Bartek et al., 1985a)
using peroxidase conjugated rabbit anti-mouse immuno-
globulin antiserum (Dako, Copenhagen, Denmark) as the
second antibody, diaminobenzidine (Sigma, Deisenhofen,
FRG) as chromogen and haematoxylin to counterstain
nuclei.
Gel electrophoresis and immunoblots
Whole tissue lysates from several 20p1m frozen sections of
selected breast tumours were made directly in sample buffer
as described by Burchell et al. (1983). The proteins were
separated by SDS-PAGE on a 12.5% polyacrylamide gel
with a 5% stacking gel. Transfer of the separated proteins
onto nitrocellulose membrane and immunoenzymatic
staining were performed as previously described (Batrtek et
al., 1985a). Molecular weight of the bands stained by the
antibodies was determined by comparison with positions of
prestained molecular weight markers (Bethesda Research,
Gaithersburg, MD) which were run in parallel in the same
sample buffer.
Collagen gel culture
Human mammary gland epithelial organoids were prepared
by enzymatic digestion of reduction mammoplasty tissue as
described by Stampfer et al. (1980). The organoids were
embedded in 0.3% collagen gels (Durban et al., 1986) and
cultured in RPMI-1640 medium supplemented with 10%
foetal calf serum, insulin (5 pgml-1), hydrocortisone
(1 pgml-1), transferrin (5 pgml-1) and epidermal growth
factor (5 ngml- 1). In order to estimate proliferative activity,
2 pCiml-1 of [3H]-thymidine (Radiochemical Centre,
Amersham, Buckinhamshire, UK) was added to duplicate
cultures on days 4, 7 and 10 of the culture period.
Incubation was terminated after 2h: the collagen gels were
washed in PBS for 40min, soaked in Tissue-Tek II OCT
compound (Miles Labs., Vienna, Austria) for 30min at room
temperature and frozen on solid CO2 before sectioning.
Autoradiography
Frozen sections of the collagen gel 'blocks' were fixed in a
mixture of cold methanol/acetone (1:1) for 10min, washed in
PBS and stained with the antibodies using the immuno-
peroxidase method described above. Alternatively, parallel
sections were air dried after fixation and processed for
autoradiography employing the standard stripping film
technique with AR-10 emulsion (Kodak, Hemel Hempstead,
UK). After 10 days' exposure at 4°C, the slides were
developed and nuclei lightly stained in haematoxylin.
Results
Normal resting breast
The epithelial cells lining the ducts and alveoli in samples of
normal resting mammary gland (i.e. tissues from breasts
without any detectable tumour) were unstained with the anti-
HLA-DR antibody (Figure 1). In contrast, there was a small
proportion (5-10%) of HLA-DR-positive epithelial cells in 2
out of 4 samples of apparently normal uninvolved areas of
breast tissue removed with cancers at mastectomy. The
Table I HLA-DR antigens in benign and malignant breast lesions
No. ofcases classifiedaccording
No. of to % oftumour cells stained by TAL-JB5
cases
Tumour type examined 0% 1% 2-25% 26-100%
Benign lesions (total) (50) (13) (20) (16) (1)
Fibroadenoma 10 - 4 6 -
Fibrocystic disease 25 7 9 9
Cystosarcoma phyllodes 11 5 5 1
Intraductal papilloma 3 1 2 -
Lactating adenoma 1 - - - 1
Carcinomas (total) (72) (29) (30) (8) (5)
Infiltrating ductal ca 39 16 17 3 3
Infiltrating lobular ca 8 2 4 2
Lobular in situ ca 3 - 2 1
Medullary ca 5 1 2 - 2
Paget's disease 2 1 1
Papillary ca 1 1 - -
Adenoid cystic ca 6 2 3 1
Anaplastic poorly
differentiated ca 2 1 1
Male breast ca 2 1 - 1
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Figure 1 Normal resting breast epithelium is unstained while a
few infiltrating mononuclear cells in the stroma express HLA-
DR antigens (x 160).
Figure 2 Normal breast tissue from the 29th week of gestation
shows homogeneous staining of the acinar epithelium as well as
most of the infiltrating cells. Note the lack of HLA-DR
expression in ductal epithelial cells (x 100).
VP
Figure 3 Patchy HLA-DR positivity of a fibroadenoma with
sparse, evenly distributed mononuclear cell infiltrate ( x 160).
Figure 4 Almost homogeneously
fibroadenoma with relatively high
leukocytes (x 100).





Figure 5 High level of HLA-DR expression in a lactating
adenoma (x 100).
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Figure 6 HLA-DR-positive tumour cell nests of an infiltrating




Figure 7 Homogeneous positivity of staining for HLA-DR
antigens in a medullary breast carcinoma ( x 160).
Figure 8 Ductal carcinoma nodule with only rare HLA-DR-
positive cells ( x 160).730 J. BARTEK et al.
mononuclear cellular infiltrate was sparse in all the above
mentioned samples of the normal breast showing only few
cells stained by TAL-1B5 (Figure 1).
Differentiating mammary gland
The immunoperoxidase staining of sections of human
mammary gland tissues at different stages of physiological
differentiation revealed drammatic changes of HLA-DR
expression. Thus, we found nearly all acinar epithelial cells
and some ductal epithelial cells positive in both late
pregnancy (Figure 2) and lactation. On the other hand, the
staining pattern of epithelial cells in sections of two cases of
the post-weaning (regressing) breast was heterogeneous with
considerably fewer positive cells than in the samples of the
late-pregnant or lactating mammary gland. In comparison
with the resting breast somewhat increased density of the
mononuclear cell infiltrate, partly expressing HLA-DR
antigens, was noted in the late-pregnant, lactating and
regressing mammary gland tissue. In common with the
resting gland, some mononuclear (mainly lymphoid) cells
stained by TAL-IB5 were located directly within the
epithelial parenchyma, usually in a 'basal' position near the
basement membrane or between myoepithelial and luminal
cells.
Breast tumours
Histopathological diagnoses and immunohistochemical
staining data on sections from the samples of 50 benign and
72 malignant breast lesions are summarised in Table I.
In most benign lesions, at least a small subpopulation of
epithelial cells stained with the anti-HLA-DR antibody. In
the cases containing some positive cells, two distinct patterns
were observed. The expression of HLA-DR antigens was
usually limited to single epithelial cells or clusters of cells
and an example of this focal positivity is shown in Figure 3.
In some lesions, areas showing nearly homogeneous staining
of the majority of epithelial cells were found (Figure 4)
though the total percentage of positive epithelial cells never
exceeded 25% even in such cases. The only exception among
benign lesions was a lactating adenoma in which almost all
cells were stained (Figure 5). Total absence of epithelial cell
staining was seen in several cases of fibrocystic disease and
cystosarcoma phyllodes, where only endothelial cells and
infiltrating mononuclear cells appeared to express HLA-DR
antigens.
Breast carcinomas exhibited greater variation with respect
to the proportion of positive tumour cells than benign
lesions (see Table I). Thus, although staining patterns similar
to those seen in benign tumours, i.e. total negativity, patchy
positivity and/or more uniform staining of some areas were
observed, there was a group of cancers (-7% of the cases
examined) in which more than 30% of tumour cells stained
for HLA-DR (Figure 6). In 3 of these more positive cases,
between 70 and 95% of the carcinoma cells appeared to be
stained by the antibody against HLA-DR antigens. Among
different types of breast carcinomas, medullary carcinomas
were of special interest as 2 out of 5 belonged to that minor
group of the highly positive cases (Figure 7). The TAL-lB5
staining reaction was both membrane-associated and
cytoplasmic showing variable intensity throughout the
lesions. In addition to female breast tumours, one of the two
carcinomas of the male breast also revealed a subpopulation
of HLA-DR-positive tumour cells.
Besides the positive cases described above, there was a
considerable number of carcinomas lacking any detectable
staining with the TAL-IB5 antibody, including all 4 skin
metastases examined. Those malignant lesions which
appeared to be almost completely unstained and showed
only rare single positive cells in some tumour nodules were
also classified as negative, inasmuch as it was not possible to
be sure if the stained cells were infiltrating mononuclear cells
(macrophages) or carcinoma cells (Figure 8). The non-
malignant epithelium associated with the cancer, sometimes
morphologically indistinguishable from normal, was found
on sections of 32 carcinoma cases examined. In 70% of
these cases, the residual non-malignant epithelium revealed
focal positivity of HLA-DR antigens similar to that seen in
benign breast lesions.
To confirm that the antibody TAL-IB5 was reacting with
the same component in breast tumours as it was in lymphoid
cells (Adams et al., 1983), Western blots of gel-separated
extracts of several tumours were stained with the antibody.
The immunoblotting data were consistent with TAL-IB5
reacting with only one band in the region of 30-34kDa, even
in the extracts of carcinomas with a high proportion of
immunohistochemically positive tumour cells accompanied
by only moderately positive infiltrating leukocytes (Figure 9,
lanes 1, 2 and 3).
When the density and distribution of the mononuclear
cellular infiltration was evaluated, the patterns of the benign
and malignant lesions showed a clear difference: almost all
benign tumours contained only sparse and evenly distributed
leukocytic infiltration (Figure 3), whereas carcinomas usually
revealed dense infiltration (Figures 6,7) often with large
aggregates of leukocytes present at the periphery of the
tumour nodules. Although occasional areas in some benign
lesions were more densely infiltrated by leukocytes, especially
in some fibroadenomas (Figure 4) and intraductal papillomas,
the intensity of the infiltration rarely reached the level
commonly seen in carcinomas. The proportion of HLA-DR-
positive infiltrating leukocytes varied considerably in both
benign and malignant lesions, the TAL-IB5-stained elements
including some lymphoid cells, elongated cells reminiscent
of dendritic cells as well as monocytes-macrophages. No
obvious correlation between HLA-DR antigen expression on
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Figure 9 Immunoperoxidase staining of Western blots of gel-
separated extracts of a medullary breast carcinoma (tracks 1-3)
and cultured reduction mammoplasty organoids (tracks 4,5) with
the antibody TAL-1B5 (tracks 1,4), BA17 (tracks 2,5) and TF-1
(track 3).HLA-DR ANTIGENS ON BREAST EPITHELIUM AND TUMOURS 731
Figure 10 Reduction mammoplasty organoids on day 4 of
collagen gel culture do not stain with the TAL-lBS antibody
( x 160).
Proliferating breast epithelium in collagen gels
To see whether there was any correlation between the rate of
proliferation and the expression of HLA-DR molecules,
reduction mammoplasty organoids were cultured in collagen
gels, pulsed by tritiated thymidine and sections of these
organoids within the three-dimensional matrix were
evaluated by combining TAL-IBS immunohistochemistry
with autoradiography on parallel sections. On day 4 of
culture, sections revealed foci of organised proliferation
extending from the embedded epithelial organoids into the
collagenous matrix, the mean labelling index being
12.2+ 1.7%. From day 5 until day 10, the proliferating
organoids and their newly formed processes increased in
diameter and length showing mean thymidine labelling
indices of 9.6+ 1.4% and 6.1 +0.9% on day 7 and 10 of the
culture period, respectively. None of the organoids at any of
the three time points examined stained with the anti-HLA-
DR antibody (Figure 10). The immunohistochemical data
were confirmed on Western blots of gel-separated extracts
from the cultured mammary organoids: No positive band
was found with TAL-iB5 despite the fact that enough
protein material of epithelial origin was used for this analysis
as indicated by the 40 kDa cytokeratin band stained by the
antibody BA17 (Figure 9, lanes 4 and 5).
Discussion
Phenotypic changes which occur during tissue differentiation
as well as during development of malignancy include those
of the spectrum of cell membrane molecules, the most
obvious candidates likely to be of importance in cell-cell and
cell-matrix interactions. Among the membrane molecules
known to be involved in cellular recognition, the class II
molecules are of special interest being the products of a
multigene family expressed in a differentiation-dependent or
activation-dependent manner on a variety of cell types
including several epithelia (see Radka et al., 1986 and
Forsum et al., 1985, for review).
As far as mammary gland differentiation is concerned,
Klareskog et al. (1980) reported induction of Ia antigens in
guinea pig mammary gland epithelium in pregnancy and
following administration of lactotropic hormones. Newman
et al. (1980) described HLA-DR antigens on lactating human
breast epithelium and isolated milk fat globule membranes
suggesting that differentiation-associated changes of class II
antigens similar to those found in guinea pigs (Klareskog et
al., 1980) might occur in humans as well but, to our
knowledge, no further data on this topic have since been
published. The available data on HLA-DR expression in
normal resting breast epithelium include both negative
(Newman et al., 1980; Bernard et al., 1984) and positive
(Bhan & Des Marais, 1983; Natali et al., 1983) reports. In
the present study, we found high amounts of HLA-DR
antigens on human breast epithelium at late pregnancy and
lactation, whereas diminished expression and total absence of
staining was observed in samples from the regressing (post
weaning) period and in the normal resting breast,
respectively. We believe this is the first report concerning the
expression of HLA-DR antigens at all important stages of
human breast differentiation and our results support the
notion that the changes follow in humans a similar pattern
to that in guinea pigs (Klareskog et al., 1980; and this
report). Furthermore, our findings on the absence of HLA-
DR molecules in normal resting breast epithelium obtained
from reduction mammoplasties and from apparently healthy
women killed in road accidents, as opposed to occasional
patchy positivity of the TAL-IB5 antibody staining on
'normal' breast epithelium obtained from mastectomies,
provide a possible explanation of the conflicting results
reported by various investigators for normal mammary gland
epithelium. Thus, the authors who reported the lack of
staining for HLA-DR antigens used reduction mammoplasty
as their material source (Newman et al., 1980; Bernard et al.,
1984) while in both positive reports (Bhan and Des Marais,
1983; Natali et al., 1983), the uninvolved 'normal' tissues
removed with tumours at mastectomy were used. Although
the transient patchy expression of class II molecules in the
normal human resting breast epithelium, e.g. at a certain
stage in the menstrual cycle, cannot be excluded at present,
our data together with those published by the above
mentioned authors rather suggest occasional aberrant HLA-
DR expression on the 'normal' epithelium of the cancerous
breasts, thus providing another warning against the use of
uninvolved mastectomy tissues as controls in the studies of
various aspects of breast cancer biology.
In contrast to Bernard et al. (1984) who reported no
staining with an anti-HLA-DR monoclonal antibody on any
of the 10 fibroadenomas examined, we found the majority of
the benign breast lesions heterogeneously positive, the top
values for the stained epithelial cells being about 15-25%.
The exceptional case of the lactating adenoma revealed
almost homogeneous positivity with TAL-IB5, thus
resembling the phenotype of the lactating breast epithelium.
Our immunohistochemical study of 50 cases of the benign
breast lesions generally confirmed and somewhat extended
the findings by Bhan and Des Marais (1983) and Whitwell et
al. (1984) of the heterogeneous expression of HLA-DR
antigens by a proportion of the epithelial cells in the benign
human mammary tumours.
The results of our present study based on the examination
of the large panel of breast carcinomas do not support the
notion that the expression of HLA-DR antigens by the
malignant tumour cells is a rare (Bhan & Des Marais, 1983)
or even non-existent (Hurliman & Saraga, 1985) event. The
variability of staining for HLA-DR on the breast carcinoma
cells reported here is consistent with previous immunohisto-
chemical data published by Natali et al. (1983), Whitwell et
al. (1984) and Gottlinger et al. (1985). The use of paraffin-
embedded tissue sections which provide superior preservation
of morphologic features, rather than frozen sections
employed by the investigators referred to above, permitted
more definitive analysis, a factor that becomes critical in the
attempt to discriminate between a wholly negative tissue or
one which contains some scattered positive carcinoma cells.
The lower resolution limits of cryostat sections together with
their commonly smaller size and the general lack of any
precise criteria by which a tumour might be classified as
positive represent just a few out of the many factors
potentially responsible for the discrepancies reported by
different authors. To exclude the possibility that the anti-
HLA-DR antibody used in our study detected some cross-
reacting epitope of a molecule present on the breast tumour
cells, in addition to HLA-DR antigens present on infiltrating
leukocytes, we deployed the immunoblotting technique with
tumour lysates separated by SDS-PAGE. The fact that TAL-732 J. BARTEK et al.
IB5 always revealed only the band predicted for the HLA-
DR polypeptides supports our conclusion that the positive
staining was due to genuine HLA-DR antigens. One
observation of potential importance is the existence of a
small group of breast carcinomas expressing high levels of
HLA-DR molecules (this study, Gottlinger et al., 1985; Bhan
& Des Marais, 1983) and future efforts correlating clinical
parameters of breast carcinomas with their HLA-DR
phenotype may be warranted.
The mechanisms which regulate the expression of class II
molecules on mammary gland epithelial cells are poorly
understood. Recent evidence suggests that recombinant
human gamma interferon, an inducer of HLA-DR
expression in competent immune cells, induces the synthesis
of HLA-DR molecules by various human breast cancer cell
lines in vitro (Gastl et al., 1985). The expression of class II
antigens in guinea pig mammary gland epithelial cells is
induced by pregnancy and lactation and can also be induced
by exogeneous administration of lactotropic hormones
(Klareskog et al., 1980) suggesting hormonal regulation of
this phenomenon. In a similar fashion, the data of Newman
et al. (1980) extended by our present results demonstrate
reversible pregnancy-associated induction of HLA-DR
antigens on normal human breast epithelium. Furthermore,
recent experiments of Bernard et al. (1986) have shown that
prolactin added to culture medium increases class II
antigenic expression by MCF-7 breast cancer cell line.
Increased levels of HLA-DR antigens on epithelial cells in
late pregnancy, lactation as well as in some breast tumours,
i.e. conditions known to be associated with higher
proliferation rate, suggested to us a possible relationship
between the increased mitotic rate and the induction of
HLA-DR molecules on human mammary gland epithelial
cells. In this context, it is interesting that the expression of
HLA-DR antigens in endometrial epithelium was reported to
parallel the rise and fall of DNA synthesis and mitoses
(Tabibzadeh et al., 1986) though this correlation was not
found in a previous study by Ferguson et al. (1985). To test
the hypothetical association of the HLA-DR expression with
proliferation, we deployed the collagen gel culture of breast
epithelial organoids pulsed with tritiated thymidine followed
by the combination of immunohistochemical staining for
HLA-DR and autoradiography. We believe the analysis of
this in vitro model demonstrates for the first time that
proliferation itself, even at a high rate, is not sufficient for
the induction of class II antigens on normal human
mammary gland epithelium. This conclusion is in accordance
with the findings by Gastl et al. (1985) that HLA-DR
expression induced by gamma interferon in several breast
cancer cell lines did not depend on proliferation but required
intact RNA and protein synthesis.
It is presently far from clear what the biological role of
class II molecules on either epithelial cells or carcinomas is.
Speculations concerning normal mammary gland epithelium
include e.g. involvement of epithelial class II antigens in
recruitment of lymphoid cells in lactation as a part of the
enteromammary pathway of protective immunity to the
offspring (Klareskog et al., 1980; Forsum et al., 1985), and a
role in providing a system for transporting key intracellular
peptides to the extracellular milieu was suggested by Unanue
and Allen (1986) for epithelia involved in peptide transport
in general. Class II molecules on epithelial cell membranes
may be involved in antigen presentation to T-cells, as has
been suggested for thyroid epithelium which is capable of
expressing HLA-DR molecules and presenting antigens to
cloned human T lymphocytes (Londei et al., 1984). The
latter idea is particularly attractive in view of the expression
of HLA-DR antigens by some carcinomas including breast
tumours which could have implications for the induction of
immune responses to putative tumour-specific or tumour-
associated antigens. Further studies are required to test these
and other hypotheses.
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